Involvement of the Dihydropyridine Receptor and Internal Ca2+Stores in Myoblast Fusion

The process of myoblast fusion during skeletal myogenesis is calcium regulated. Both dihydropyridine receptor and ryanodine receptor are already present on muscle precursors, at the prefusional stage, before they are required for excitation–contraction coupling. Previous pharmacological studies have...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Experimental cell research 1996-03, Vol.223 (2), p.301-307
Hauptverfasser: Seigneurin-Venin, Sophie, Parrish, Elaine, Marty, Isabelle, Rieger, François, Romey, Georges, Villaz, Michel, Garcia, Luis
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 307
container_issue 2
container_start_page 301
container_title Experimental cell research
container_volume 223
creator Seigneurin-Venin, Sophie
Parrish, Elaine
Marty, Isabelle
Rieger, François
Romey, Georges
Villaz, Michel
Garcia, Luis
description The process of myoblast fusion during skeletal myogenesis is calcium regulated. Both dihydropyridine receptor and ryanodine receptor are already present on muscle precursors, at the prefusional stage, before they are required for excitation–contraction coupling. Previous pharmacological studies have shown the need for a special pool of Ca2+associated with the membrane for the fusion process to occur. We hypothesized that this pool of Ca2+is mobilized via a machinery similar to that involved in excitation–contraction coupling. The process of fusion in rat L6 muscle precursors was either totally or partially abolished in the presence of the L-type calcium channel inhibitors SR33557 and nifedipine (half inhibition towards 2 μM), respectively. The inhibition was reversible and dose-dependent. Drugs able to deplete internal calcium stores (caffeine, ryanodine, and thapsigargin) were also tested on the fusion. Both caffeine and thapsigargin drastically inhibited fusion whereas ryanodine had no effect. This suggests that fusion may be controlled by internal pools of Ca2+but that its regulation may be insensitive to ryanodine. We presumed that an early form of the ryanodine receptor may exist, with different pharmacological properties than the adult forms. Indeed, Western blot analysis of pre- and postfusional L6 cells demonstrated the presence, at the prefusional stage, of a transient form of the ryanodine receptor protein with an apparent molecular weight slightly different from those of the classical skeletal and cardiac forms. Taken together, these results support the hypothesis that the fusion process is driven by a mechanism involving both the dihydropyridine receptor (α1 subunit of the L-type Ca2+channel) and the internal stores of Ca2+. The machinery underlying this mechanism might consist of slightly different forms of the classic molecules that in adult muscle ensure excitation–contraction coupling. It remains to be seen, however, whether the mobilization of the internal pool of Ca2+is triggered by the type of mechanism already described in skeletal muscle.
doi_str_mv 10.1006/excr.1996.0085
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_77984148</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0014482796900853</els_id><sourcerecordid>77984148</sourcerecordid><originalsourceid>FETCH-LOGICAL-c271t-fa5a6c84064c20b60d5fb0bc876e1dc740cdf63c309c7b6aa95450857bca60893</originalsourceid><addsrcrecordid>eNp1kEFrGzEQRkVpcB2319wKOvVS1hmttZL2GNw6MSQEkrZXoZVmscJacqS1if99d7HJLaeB-d58MI-QKwZzBiCu8c2mOatrMQdQ1ScyZVBDUfKy_EymAIwXXJXyC7nM-QUGRDExIRMlhgTklPxbh0PsDrjF0NPY0n6D9JffHF2Ku2PyzgekT2hx18dETXB0HXpMwXR0acqfz8MWM_WBPhxj05nc09U--xi-kovWdBm_neeM_F39_rO8K-4fb9fLm_vClpL1RWsqI6ziILgtoRHgqraBxiopkDkrOVjXioVdQG1lI4ypK14Nb8rGGgGqXszIj1PvLsXXPeZeb3222HUmYNxnLWWtOONqAOcn0KaYc8JW75LfmnTUDPQoUo8i9ShSjyKHg-_n5n2zRfeOn80NuTrlOLx38Jh0th6DRecT2l676D-q_g9_F4KO</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>77984148</pqid></control><display><type>article</type><title>Involvement of the Dihydropyridine Receptor and Internal Ca2+Stores in Myoblast Fusion</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Seigneurin-Venin, Sophie ; Parrish, Elaine ; Marty, Isabelle ; Rieger, François ; Romey, Georges ; Villaz, Michel ; Garcia, Luis</creator><creatorcontrib>Seigneurin-Venin, Sophie ; Parrish, Elaine ; Marty, Isabelle ; Rieger, François ; Romey, Georges ; Villaz, Michel ; Garcia, Luis</creatorcontrib><description>The process of myoblast fusion during skeletal myogenesis is calcium regulated. Both dihydropyridine receptor and ryanodine receptor are already present on muscle precursors, at the prefusional stage, before they are required for excitation–contraction coupling. Previous pharmacological studies have shown the need for a special pool of Ca2+associated with the membrane for the fusion process to occur. We hypothesized that this pool of Ca2+is mobilized via a machinery similar to that involved in excitation–contraction coupling. The process of fusion in rat L6 muscle precursors was either totally or partially abolished in the presence of the L-type calcium channel inhibitors SR33557 and nifedipine (half inhibition towards 2 μM), respectively. The inhibition was reversible and dose-dependent. Drugs able to deplete internal calcium stores (caffeine, ryanodine, and thapsigargin) were also tested on the fusion. Both caffeine and thapsigargin drastically inhibited fusion whereas ryanodine had no effect. This suggests that fusion may be controlled by internal pools of Ca2+but that its regulation may be insensitive to ryanodine. We presumed that an early form of the ryanodine receptor may exist, with different pharmacological properties than the adult forms. Indeed, Western blot analysis of pre- and postfusional L6 cells demonstrated the presence, at the prefusional stage, of a transient form of the ryanodine receptor protein with an apparent molecular weight slightly different from those of the classical skeletal and cardiac forms. Taken together, these results support the hypothesis that the fusion process is driven by a mechanism involving both the dihydropyridine receptor (α1 subunit of the L-type Ca2+channel) and the internal stores of Ca2+. The machinery underlying this mechanism might consist of slightly different forms of the classic molecules that in adult muscle ensure excitation–contraction coupling. It remains to be seen, however, whether the mobilization of the internal pool of Ca2+is triggered by the type of mechanism already described in skeletal muscle.</description><identifier>ISSN: 0014-4827</identifier><identifier>EISSN: 1090-2422</identifier><identifier>DOI: 10.1006/excr.1996.0085</identifier><identifier>PMID: 8601407</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Animals ; Caffeine - pharmacology ; Calcium - metabolism ; Calcium Channel Blockers - pharmacology ; Calcium Channels - analysis ; Calcium Channels - physiology ; Calcium Channels, L-Type ; Calcium-Transporting ATPases - antagonists &amp; inhibitors ; Cell Fusion - drug effects ; Cell Fusion - physiology ; Cell Line ; Creatine Kinase - metabolism ; Enzyme Inhibitors - pharmacology ; Indolizines - pharmacology ; Ion Channel Gating ; Muscle Fibers, Skeletal - chemistry ; Muscle Fibers, Skeletal - cytology ; Muscle Fibers, Skeletal - metabolism ; Muscle Proteins - analysis ; Muscle Proteins - physiology ; Muscles - embryology ; Nifedipine - pharmacology ; Phenethylamines - pharmacology ; Rats ; Ryanodine - pharmacology ; Ryanodine Receptor Calcium Release Channel ; Terpenes - pharmacology ; Thapsigargin</subject><ispartof>Experimental cell research, 1996-03, Vol.223 (2), p.301-307</ispartof><rights>1996 Academic Press</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c271t-fa5a6c84064c20b60d5fb0bc876e1dc740cdf63c309c7b6aa95450857bca60893</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0014482796900853$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,65309</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8601407$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Seigneurin-Venin, Sophie</creatorcontrib><creatorcontrib>Parrish, Elaine</creatorcontrib><creatorcontrib>Marty, Isabelle</creatorcontrib><creatorcontrib>Rieger, François</creatorcontrib><creatorcontrib>Romey, Georges</creatorcontrib><creatorcontrib>Villaz, Michel</creatorcontrib><creatorcontrib>Garcia, Luis</creatorcontrib><title>Involvement of the Dihydropyridine Receptor and Internal Ca2+Stores in Myoblast Fusion</title><title>Experimental cell research</title><addtitle>Exp Cell Res</addtitle><description>The process of myoblast fusion during skeletal myogenesis is calcium regulated. Both dihydropyridine receptor and ryanodine receptor are already present on muscle precursors, at the prefusional stage, before they are required for excitation–contraction coupling. Previous pharmacological studies have shown the need for a special pool of Ca2+associated with the membrane for the fusion process to occur. We hypothesized that this pool of Ca2+is mobilized via a machinery similar to that involved in excitation–contraction coupling. The process of fusion in rat L6 muscle precursors was either totally or partially abolished in the presence of the L-type calcium channel inhibitors SR33557 and nifedipine (half inhibition towards 2 μM), respectively. The inhibition was reversible and dose-dependent. Drugs able to deplete internal calcium stores (caffeine, ryanodine, and thapsigargin) were also tested on the fusion. Both caffeine and thapsigargin drastically inhibited fusion whereas ryanodine had no effect. This suggests that fusion may be controlled by internal pools of Ca2+but that its regulation may be insensitive to ryanodine. We presumed that an early form of the ryanodine receptor may exist, with different pharmacological properties than the adult forms. Indeed, Western blot analysis of pre- and postfusional L6 cells demonstrated the presence, at the prefusional stage, of a transient form of the ryanodine receptor protein with an apparent molecular weight slightly different from those of the classical skeletal and cardiac forms. Taken together, these results support the hypothesis that the fusion process is driven by a mechanism involving both the dihydropyridine receptor (α1 subunit of the L-type Ca2+channel) and the internal stores of Ca2+. The machinery underlying this mechanism might consist of slightly different forms of the classic molecules that in adult muscle ensure excitation–contraction coupling. It remains to be seen, however, whether the mobilization of the internal pool of Ca2+is triggered by the type of mechanism already described in skeletal muscle.</description><subject>Animals</subject><subject>Caffeine - pharmacology</subject><subject>Calcium - metabolism</subject><subject>Calcium Channel Blockers - pharmacology</subject><subject>Calcium Channels - analysis</subject><subject>Calcium Channels - physiology</subject><subject>Calcium Channels, L-Type</subject><subject>Calcium-Transporting ATPases - antagonists &amp; inhibitors</subject><subject>Cell Fusion - drug effects</subject><subject>Cell Fusion - physiology</subject><subject>Cell Line</subject><subject>Creatine Kinase - metabolism</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>Indolizines - pharmacology</subject><subject>Ion Channel Gating</subject><subject>Muscle Fibers, Skeletal - chemistry</subject><subject>Muscle Fibers, Skeletal - cytology</subject><subject>Muscle Fibers, Skeletal - metabolism</subject><subject>Muscle Proteins - analysis</subject><subject>Muscle Proteins - physiology</subject><subject>Muscles - embryology</subject><subject>Nifedipine - pharmacology</subject><subject>Phenethylamines - pharmacology</subject><subject>Rats</subject><subject>Ryanodine - pharmacology</subject><subject>Ryanodine Receptor Calcium Release Channel</subject><subject>Terpenes - pharmacology</subject><subject>Thapsigargin</subject><issn>0014-4827</issn><issn>1090-2422</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kEFrGzEQRkVpcB2319wKOvVS1hmttZL2GNw6MSQEkrZXoZVmscJacqS1if99d7HJLaeB-d58MI-QKwZzBiCu8c2mOatrMQdQ1ScyZVBDUfKy_EymAIwXXJXyC7nM-QUGRDExIRMlhgTklPxbh0PsDrjF0NPY0n6D9JffHF2Ku2PyzgekT2hx18dETXB0HXpMwXR0acqfz8MWM_WBPhxj05nc09U--xi-kovWdBm_neeM_F39_rO8K-4fb9fLm_vClpL1RWsqI6ziILgtoRHgqraBxiopkDkrOVjXioVdQG1lI4ypK14Nb8rGGgGqXszIj1PvLsXXPeZeb3222HUmYNxnLWWtOONqAOcn0KaYc8JW75LfmnTUDPQoUo8i9ShSjyKHg-_n5n2zRfeOn80NuTrlOLx38Jh0th6DRecT2l676D-q_g9_F4KO</recordid><startdate>19960315</startdate><enddate>19960315</enddate><creator>Seigneurin-Venin, Sophie</creator><creator>Parrish, Elaine</creator><creator>Marty, Isabelle</creator><creator>Rieger, François</creator><creator>Romey, Georges</creator><creator>Villaz, Michel</creator><creator>Garcia, Luis</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19960315</creationdate><title>Involvement of the Dihydropyridine Receptor and Internal Ca2+Stores in Myoblast Fusion</title><author>Seigneurin-Venin, Sophie ; Parrish, Elaine ; Marty, Isabelle ; Rieger, François ; Romey, Georges ; Villaz, Michel ; Garcia, Luis</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c271t-fa5a6c84064c20b60d5fb0bc876e1dc740cdf63c309c7b6aa95450857bca60893</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>Animals</topic><topic>Caffeine - pharmacology</topic><topic>Calcium - metabolism</topic><topic>Calcium Channel Blockers - pharmacology</topic><topic>Calcium Channels - analysis</topic><topic>Calcium Channels - physiology</topic><topic>Calcium Channels, L-Type</topic><topic>Calcium-Transporting ATPases - antagonists &amp; inhibitors</topic><topic>Cell Fusion - drug effects</topic><topic>Cell Fusion - physiology</topic><topic>Cell Line</topic><topic>Creatine Kinase - metabolism</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>Indolizines - pharmacology</topic><topic>Ion Channel Gating</topic><topic>Muscle Fibers, Skeletal - chemistry</topic><topic>Muscle Fibers, Skeletal - cytology</topic><topic>Muscle Fibers, Skeletal - metabolism</topic><topic>Muscle Proteins - analysis</topic><topic>Muscle Proteins - physiology</topic><topic>Muscles - embryology</topic><topic>Nifedipine - pharmacology</topic><topic>Phenethylamines - pharmacology</topic><topic>Rats</topic><topic>Ryanodine - pharmacology</topic><topic>Ryanodine Receptor Calcium Release Channel</topic><topic>Terpenes - pharmacology</topic><topic>Thapsigargin</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Seigneurin-Venin, Sophie</creatorcontrib><creatorcontrib>Parrish, Elaine</creatorcontrib><creatorcontrib>Marty, Isabelle</creatorcontrib><creatorcontrib>Rieger, François</creatorcontrib><creatorcontrib>Romey, Georges</creatorcontrib><creatorcontrib>Villaz, Michel</creatorcontrib><creatorcontrib>Garcia, Luis</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Experimental cell research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Seigneurin-Venin, Sophie</au><au>Parrish, Elaine</au><au>Marty, Isabelle</au><au>Rieger, François</au><au>Romey, Georges</au><au>Villaz, Michel</au><au>Garcia, Luis</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Involvement of the Dihydropyridine Receptor and Internal Ca2+Stores in Myoblast Fusion</atitle><jtitle>Experimental cell research</jtitle><addtitle>Exp Cell Res</addtitle><date>1996-03-15</date><risdate>1996</risdate><volume>223</volume><issue>2</issue><spage>301</spage><epage>307</epage><pages>301-307</pages><issn>0014-4827</issn><eissn>1090-2422</eissn><abstract>The process of myoblast fusion during skeletal myogenesis is calcium regulated. Both dihydropyridine receptor and ryanodine receptor are already present on muscle precursors, at the prefusional stage, before they are required for excitation–contraction coupling. Previous pharmacological studies have shown the need for a special pool of Ca2+associated with the membrane for the fusion process to occur. We hypothesized that this pool of Ca2+is mobilized via a machinery similar to that involved in excitation–contraction coupling. The process of fusion in rat L6 muscle precursors was either totally or partially abolished in the presence of the L-type calcium channel inhibitors SR33557 and nifedipine (half inhibition towards 2 μM), respectively. The inhibition was reversible and dose-dependent. Drugs able to deplete internal calcium stores (caffeine, ryanodine, and thapsigargin) were also tested on the fusion. Both caffeine and thapsigargin drastically inhibited fusion whereas ryanodine had no effect. This suggests that fusion may be controlled by internal pools of Ca2+but that its regulation may be insensitive to ryanodine. We presumed that an early form of the ryanodine receptor may exist, with different pharmacological properties than the adult forms. Indeed, Western blot analysis of pre- and postfusional L6 cells demonstrated the presence, at the prefusional stage, of a transient form of the ryanodine receptor protein with an apparent molecular weight slightly different from those of the classical skeletal and cardiac forms. Taken together, these results support the hypothesis that the fusion process is driven by a mechanism involving both the dihydropyridine receptor (α1 subunit of the L-type Ca2+channel) and the internal stores of Ca2+. The machinery underlying this mechanism might consist of slightly different forms of the classic molecules that in adult muscle ensure excitation–contraction coupling. It remains to be seen, however, whether the mobilization of the internal pool of Ca2+is triggered by the type of mechanism already described in skeletal muscle.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>8601407</pmid><doi>10.1006/excr.1996.0085</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0014-4827
ispartof Experimental cell research, 1996-03, Vol.223 (2), p.301-307
issn 0014-4827
1090-2422
language eng
recordid cdi_proquest_miscellaneous_77984148
source MEDLINE; Elsevier ScienceDirect Journals
subjects Animals
Caffeine - pharmacology
Calcium - metabolism
Calcium Channel Blockers - pharmacology
Calcium Channels - analysis
Calcium Channels - physiology
Calcium Channels, L-Type
Calcium-Transporting ATPases - antagonists & inhibitors
Cell Fusion - drug effects
Cell Fusion - physiology
Cell Line
Creatine Kinase - metabolism
Enzyme Inhibitors - pharmacology
Indolizines - pharmacology
Ion Channel Gating
Muscle Fibers, Skeletal - chemistry
Muscle Fibers, Skeletal - cytology
Muscle Fibers, Skeletal - metabolism
Muscle Proteins - analysis
Muscle Proteins - physiology
Muscles - embryology
Nifedipine - pharmacology
Phenethylamines - pharmacology
Rats
Ryanodine - pharmacology
Ryanodine Receptor Calcium Release Channel
Terpenes - pharmacology
Thapsigargin
title Involvement of the Dihydropyridine Receptor and Internal Ca2+Stores in Myoblast Fusion
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T11%3A02%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Involvement%20of%20the%20Dihydropyridine%20Receptor%20and%20Internal%20Ca2+Stores%20in%20Myoblast%20Fusion&rft.jtitle=Experimental%20cell%20research&rft.au=Seigneurin-Venin,%20Sophie&rft.date=1996-03-15&rft.volume=223&rft.issue=2&rft.spage=301&rft.epage=307&rft.pages=301-307&rft.issn=0014-4827&rft.eissn=1090-2422&rft_id=info:doi/10.1006/excr.1996.0085&rft_dat=%3Cproquest_cross%3E77984148%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=77984148&rft_id=info:pmid/8601407&rft_els_id=S0014482796900853&rfr_iscdi=true